#5SmartReads - November 30, 2021
Hitha on COVID antivirals, Hanukkah, and Amrit Kaur
This is very good news. And what’s even better is that Merck is doing the same with its own anti-viral.
Granting sublicenses and waiving royalties on these medicines sold in the countries covered by the Medicines Patents Pool is what we need now (and have needed for some time).
More of this, please. It’s how we get into an endemic state.